bb2121,idecabtagene vicleucel
2seventy bio,bms
['car t', 'abecma', 'karmma', 'bmsnews', 'bms']
real world experience of #abecma from u.s. myeloma car t consortium at 2022
safety efficacy similar to karmma despite many ineligible for the trial. proud to be a part of this collaborative effort. 
Assistant Professor Hematology/BMT @Muschollings Plasma cell disorders/ BMT/Cellular Therapy. Opinions are my own and not employer’s